LUCYW insider files Form 144 to sell 1,485 shares on 08/19/2025

Rhea-AI Filing Summary

Form 144 notice: A person affiliated with Innovative Eyewear, Inc. (ticker LUCYW) notified a proposed sale of 1,485 common shares08/19/2025. The filing lists an aggregate market value of $2,889.95 for the shares and reports 4,574,602 shares outstanding. The securities were acquired the same day as an RSU grant dated 08/19/2025 for 4,800 shares, with cash listed as the payment method. The filer attests they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Small size: The proposed sale of 1,485 shares equals ~0.0325% of the 4,574,602 shares outstanding, suggesting minimal market impact
• Acquisition transparency: Securities were acquired via an RSU grant on 08/19/2025 with cash payment recorded, clarifying the origin of the shares
• Attestation: Filer signed a representation they are not aware of any undisclosed material adverse information

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine small-volume insider sale from recent RSU grant; not likely material to valuation.

The filing documents a proposed sale of 1,485 common shares valued at $2,889.95, executed through Raymond James on 08/19/2025. The shares were acquired as a RSU grant on the same date (4,800 shares granted) and paid in cash. Relative to the issuer's reported 4,574,602 shares outstanding, the proposed sale represents approximately 0.0325% of outstanding stock, indicating immaterial direct dilution or market impact. There is no disclosure of other recent sales in the past three months.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 formalities; filer asserts no material nonpublic information.

The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information and supplies broker details (Raymond James). The transaction stems from a contemporaneous RSU grant, with cash payment noted. No plan adoption date or 10b5-1 trading plan is indicated in the remarks section. Based on the data provided, this is a routine compliance filing rather than a material governance event.

08/19/2025 - 01:17 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	1485	2889.95	4574602	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	RSU Grant	Issuer			4800	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for LUCYW report?

The Form 144 reports a proposed sale of 1,485 common shares through Raymond James on 08/19/2025 with an aggregate market value of $2,889.95.

How many shares outstanding does Innovative Eyewear have per the filing?

The filing lists 4,574,602 shares outstanding.

How were the securities being sold acquired?

The securities were acquired as an RSU grant dated 08/19/2025, showing 4,800 shares were granted and payment method noted as cash.

Who is the broker handling the proposed sale?

The broker listed is Raymond James & Associates located at 880 Carillon Parkway, St. Petersburg, FL 33716.

Does the filing disclose any sales in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.